comparemela.com

Latest Breaking News On - Russell szmulewitz - Page 1 : comparemela.com

Kay Macleod named Associate Director for Basic Sciences for the University of Chicago Medicine Comprehensive Cancer Center

Kay Macleod named Associate Director for Basic Sciences for the University of Chicago Medicine Comprehensive Cancer Center

THE PROSTATE CANCER FOUNDATION AND BAYER ANNOUNCE FIRST EVER BAYER-PCF DAROLUTAMIDE CHALLENGE AWARDS

THE PROSTATE CANCER FOUNDATION AND BAYER ANNOUNCE FIRST EVER BAYER-PCF DAROLUTAMIDE CHALLENGE AWARDS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Corcept Therapeutics (CORT) Q2 2022 Earnings Call Transcript

Experts push for new cancer drug dosing recommendations

This article originally appeared on Undark. When chatting at cocktail parties about his job, Mark Ratain, an oncologist and pharmacologist at the University of Chicago, often asks a short riddle: Your doctor gives you a prescription for a new drug. The pharmacist says, Make sure you take it on an empty stomach, twice a day. What do you think would happen if you took it with food? Most don t get the answer right. Nobody would ever say, Well, I could die from an overdose, Ratain says. Advertisement: That s exactly what could happen to anyone taking the drug nilotinib approved by the U.S. Food and Drug Administration in 2007 to treat the blood cancer chronic myelogenous leukemia. The drug is among the most effective cancer therapies; a patient taking it may have a 96 percent chance of surviving the cancer for at least six years, according to one of the most recent long-term studies. But the FDA-approved label for nilotinib carries a black box warning: Take it on an empty s

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.